Skip to content

Continuous Positive Airway Pressure (CPAP) for Primary Care

Validation of a Programme of Treatment and Follow-Up for Obstructive Sleep Apnea (OSA) Patients to be Applied by General Practitioners (GPs). Collaborative Network System Between GPs, CPAP Provider Enterprise and Sleep Specialists

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02459548
Acronym
CPAP-SU-MAP
Enrollment
220
Registered
2015-06-02
Start date
2014-02-28
Completion date
2016-05-31
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSA

Keywords

OSA, CPAP treatment, Primary care, Efficacy

Brief summary

The objective of the study is to compare the results of a follow-up and treatment coordinate and interactive program performed by the General Practitioners (GP) for Obstructive Sleep Apnea (OSA) patients treated with positive continuous pressure (CPAP) vs. usual control by sleep specialists from the sleep unit. METHODOLOGY: DESIGN: Randomized comparative study. It will include patients with diagnosis of severe OSA that should start treatment with CPAP. Participating center is Hospital Universitario Araba in Vitoria-Gasteiz (Spain). These patients will be randomized to two monitoring groups : 1 monitoring in the sleep unit; 2: monitoring in primary care consultations by the General Practitioners (GP), once the OSA diagnosis has been made and it was indicated the treatment with CPAP. Patients will be carried out in both groups the same follow-up visits in two study arms: basal, 1 month, 3 month and 6 months. PRIMARY OUTCOME: To compare the objective CPAP compliance treatment in the two study groups, so that use \>= 4h/day is defined as good adherence to the treatment. SECONDARY OUTCOMES: 1)To evaluate the level of patient's satisfaction by visual-analogical scales and quality of life tests; 2) to establish the clinical improvement by somnolence and sleep scales; 3) To determine the numbers of CPAP complications, type, severity and duration; 4) To figure-out the level of take care of the CPAP machine, substitutions and complements, assistance and technical incidents; 5) Cost-effectiveness analysis.

Interventions

OTHERFollow up in Sleep Unit Group

Compare the results of a program of treatment and follow-up by Primary Care in patients with obstructive sleep apnea on CPAP treatment, versus the usual practice of control by the Sleep Unit.

OTHERFollow up in Primary Care Group

Compare the results of a program of treatment and follow-up by Primary Care in patients with obstructive sleep apnea on CPAP treatment, versus the usual practice of control by the Sleep Unit.

Sponsors

Spain:Health Department. Basque Government.
CollaboratorUNKNOWN
Linde Health Care
CollaboratorOTHER
Hospital Universitario Araba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women over 18 years old. * Patients with OSA diagnosis performed in the sleep unit * Written informed consent signed.

Exclusion criteria

* Previous CPAP treatment for OSA diagnosis * Psycho-physical inability to complete questionnaires * Presence of any previously diagnosed sleep disorders: narcolepsy, insomnia, chronic sleep deprivations, regular use of hypnotic or sedative medications nad restless leg syndrome * Patients with respiratory diseases (overlap syndrome, hypoventilation, restrictive diseases) * A medical history that may interfere with the study objectives or, in the opinion of the investigator, compromise the conclusions.

Design outcomes

Primary

MeasureTime frameDescription
Number of hours of use per day of CPAPSix monthCompare the objective CPAP compliance treatment in the two study groups.

Secondary

MeasureTime frameDescription
Level of clinical improvement evaluated through the Epworth Sleep ScaleAt baseline and at 6 month of follow-upEvaluate the level of clinical improvement from the start of treatment until 6 months by the changes in the Epworth Sleep Scale
Patient satisfaction (visual-analogical scale)Six monthEvaluate the level of patient's satisfaction by visual-analogical scale.
Adverse events (number of CPAP complications)Six monthDetermine the number of CPAP complications (secondary effects).
Comorbidity index (Charlson index)Six monthCharlson index
Blood pressureSix monthBlood pressure measurements
Cost-effectiveness analysisSix monthCost-efficacy evaluation
Quality of life (EuroQOL test)Baseline and at 6 month of follow upEvaluate by EuroQOL test

Other

MeasureTime frameDescription
Anthropometric variables (Body mass index)Six monthBody mass index

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026